Constitutive activation of the renin-angiotensin system reduces visceral fat and improves glucose tolerance in mice

J Renin Angiotensin Aldosterone Syst. 2014 Dec;15(4):396-409. doi: 10.1177/1470320314537695. Epub 2014 Nov 4.

Abstract

Introduction: The renin-angiotensin system (RAS), and particularly angiotensin II, is involved in the control of energy balance, glucose homeostasis and kidney functions. The integrated impact of the RAS on glucose homeostasis is still a matter of debate.

Materials and methods: We used a model of constitutive RAS activation in double transgenic mice (dTGM) carrying both human angiotensinogen and human renin genes. We evaluated energy balance, measured renal functions, performed glucose and insulin tolerance tests, and used ramipril to inhibit the angiotensin-converting enzyme.

Results: dTGM had a lower physical activity and an increased food intake without change in body weight. Renal impairment was characterized by low-grade albuminuria. High urinary output secondary to polydipsia was associated with proximal tubule dysfunction. Compared to controls, dTGM had a lower hyperglycemia induced by an intraperitoneal glucose administration. This decrease was not due to changes in insulin sensitivity and/or secretion. dTGM had an increased creatinine production and a lower epididymal fat mass. Acute inhibition of angiotensin-converting enzyme with ramipril did not suppress this improved glucose tolerance profile.

Conclusion: Chronic RAS activation is not sufficient to cause insulin resistance in mice. Moreover, adaptation to constitutive RAS activation in mice results in a better glucose tolerance.

Keywords: Renin-angiotensin system; metabolism; renal function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / metabolism
  • Animals
  • Area Under Curve
  • Creatinine / blood
  • Drinking / drug effects
  • Energy Metabolism / drug effects
  • Gene Expression Regulation / drug effects
  • Glucose Tolerance Test
  • Homeostasis / drug effects
  • Humans
  • Hypertension / metabolism
  • Hypertension / physiopathology
  • Insulin / metabolism
  • Insulin Secretion
  • Intra-Abdominal Fat / drug effects
  • Intra-Abdominal Fat / metabolism*
  • Kidney Function Tests
  • Kidney Tubules, Proximal / drug effects
  • Kidney Tubules, Proximal / metabolism
  • Kidney Tubules, Proximal / pathology
  • Kidney Tubules, Proximal / ultrastructure
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Muscles / drug effects
  • Muscles / metabolism
  • Organ Size / drug effects
  • Phenotype
  • Ramipril / pharmacology
  • Renin-Angiotensin System* / drug effects

Substances

  • Insulin
  • Angiotensin II
  • Creatinine
  • Ramipril